Martin & Co. Inc. TN bought a new stake in Merck KGaA (OTCMKTS:MKGAF – Free Report) in the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 15,985 shares of the company’s stock, valued at approximately $2,054,000.
A number of other hedge funds have also recently bought and sold shares of MKGAF. Frazier Financial Advisors LLC acquired a new stake in shares of Merck KGaA during the second quarter worth approximately $25,000. Rakuten Securities Inc. acquired a new position in shares of Merck KGaA in the 2nd quarter valued at about $27,000. Bard Associates Inc. bought a new position in shares of Merck KGaA during the second quarter valued at approximately $60,000. Kilter Group LLC acquired a new position in Merck KGaA during the 2nd quarter valued at approximately $62,000. Finally, Addison Advisors LLC bought a new position in Merck KGaA during the 2nd quarter worth $90,000. Institutional investors and hedge funds own 0.10% of the company’s stock.
Merck KGaA Price Performance
Shares of OTCMKTS MKGAF opened at $163.21 on Friday. Merck KGaA has a 1-year low of $116.68 and a 1-year high of $175.56. The company has a debt-to-equity ratio of 0.27, a current ratio of 1.31 and a quick ratio of 0.84. The business’s fifty day moving average price is $162.62 and its two-hundred day moving average price is $148.46. The firm has a market capitalization of $21.09 billion, a PE ratio of 24.92 and a beta of 0.96.
Merck KGaA Company Profile
Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.
The company’s operations are organized mainly into three businesses.
Featured Stories
- Five stocks we like better than Merck KGaA
- 2 Biotech Stocks Shaping Up for Major Breakouts
- 3 Stocks Came Roaring Back—Now They’re Flashing Warning Signs
- 3 Beaten-Down Stocks That Haven’t Gotten the Message About the S&P 500’s Record Run
- Darden Restaurants Just Hit a 52-Week High–Is the Olive Garden Comeback Story Legit?
Want to see what other hedge funds are holding MKGAF? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Merck KGaA (OTCMKTS:MKGAF – Free Report).
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
